Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05390606 · ClinicalTrials.gov registry record · Phase 1
Effects of Flourish HEC and BioGenesis to Improve Conception
A Phase 1 study, sponsored by Vaginal Biome Science.
- Terminated
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
NCT05390606 is a Phase 1 study that was terminated before completion, run by Vaginal Biome Science. The registered enrollment target is 1 participants.
The verdict
NCT05390606, a Phase 1 study, was terminated before completion, sponsored by Vaginal Biome Science.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
This study intends to address whether improving the vaginal microbiome can help couples increase chances of conceiving.
Interventions
- COMBINATION_PRODUCT Flourish HEC and BioGenesis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2022-06-15 |
| Est. Completion | 2023-03-20 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05390606
The ClinicalTrials.gov registry entry for NCT05390606 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vaginal Biome Science, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Flourish HEC and BioGenesis is the first listed.
NCT05390606 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05390606 about?
NCT05390606 is a clinical study titled "Effects of Flourish HEC and BioGenesis to Improve Conception". This study intends to address whether improving the vaginal microbiome can help couples increase chances of conceiving.
What is the current status of trial NCT05390606?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2022-06-15. Estimated completion is 2023-03-20.
What interventions are being tested in trial NCT05390606?
The interventions under investigation include: Flourish HEC and BioGenesis (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT05390606?
This trial is sponsored by Vaginal Biome Science, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.